Ling Zhong

1.2k citations
38 papers · 708 indexed · h-index 15
Topics
Breast Cancer Treatment Studies (5 papers)Genomics and Phylogenetic Studies (3 papers)Nuclear Receptors and Signaling (3 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Ling Zhong

34 papers receiving 700 citations

Peers

Ling Zhong
Comparison fields: 5 of 95
  • Molecular Biology 334
  • Cancer Research 153
  • Cellular and Molecular Neuroscience 143
  • Oncology 122
  • Physiology 122
Replace Zhitao Han with:
Zhitao Han China
Valentina Caracciolo United States
Ana Lúcia Abujamra Brazil
He Huang China
Yi Dong China
Bruna Barneda‐Zahonero Spain
Yong Ho Japan
Núria Llecha Spain
Yujun Shen China
Alessio Cardinale Italy
Ling Zhong relative to Zhitao Han China Zhitao Han's profile →
Citations per field
00.5×1.6×
Zhitao Han · 1×
Citations per year

Countries citing papers authored by Ling Zhong

Since Specialization
Citations

This map shows the geographic impact of Ling Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhong more than expected).

Fields of papers citing papers by Ling Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhong. The network helps show where Ling Zhong may publish in the future.

Co-authorship network of co-authors of Ling Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Zhong. A scholar is included among the top collaborators of Ling Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Zhong. Ling Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 1
5 1
6 8
7 33
8 40
9 30
10 16
11 51
12 37
13 6
14 27
15 10
16 95
17 21
18 16
19 10
20
JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.
20

About Ling Zhong

Ling Zhong is a scholar working on Cancer Research, Molecular Medicine and Nephrology, having authored 38 papers that have together received 708 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Genomics and Phylogenetic Studies (3 papers) and Nuclear Receptors and Signaling (3 papers). The work is most often cited by research in Cancer Research (153 citations), Cellular and Molecular Neuroscience (143 citations) and Developmental Neuroscience (26 citations). Ling Zhong has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shao‐Jun Tang, Xiangling Yang, Wei Zhang, Bei Li, Yichen Li, Jun Jiang, Bei Li, Tommy Andersson, Min Huang and Yanxi Peng. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026